2020 Nov 20 - Companion Diagnostic and Biomarker Assay Development for Interrogation of Liquid and Solid Tumor Biopsies – From RNAscope to Exosomes
Robert Monroe, MD, PhD, FCAP
Chief Medical Officer, Advanced Cell Diagnostics, a Bio-Techne brand
Watch Video:
Christopher Bunker, Ph.D., MBA
Sr. Director, Business Development, Advanced Cell Diagnostics, a Bio-Techne Brand
Michael D Valentino, Ph.D.
Scientific Director of Companion Diagnostics within the Business Development team at Exosome Diagnostics, a Bio-Techne Brand
Outline:
This webinar will provide an overview of the Bio-Techne technologies being used by Biopharma for the development of biomarkers and companion diagnostic assays to support their therapeutic programs, including tissue-based and liquid biopsy approaches. In particular, the RNAscope technology and its utility as a companion diagnostic platform for tissue-based testing of biomarker expression and patient selection will be reviewed. In addition, the use of exosomes in the development of biomarkers for oncology, neurologic diseases, and other conditions will be highlighted.
